Cervical Cancer Vaccine
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you your search results in order of date.
3911 records returned
Aspirin kills 400% more people than H1N1 swine flu
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(NaturalNews) The CDC now reports that nearly 4,000 Americans have been killed by H1N1 swine flu. This number is supposed to sound big and scary, motivating millions of people to go out and pay good money to be injected with untested, unproven H1N1 vaccines. But let's put the number in perspective: Did you know that more than four times as many people are killed each year by common NSAID painkillers like aspirin?The July 1998 issue of The American Journal of Medicine explains it as follows:"Conservative calculations estimate that approximately 107,000 patients are hospitalized annually for nonsteroidal anti-inflammatory dr...
Source: NaturalNews.com - November 20, 2009 Category: Consumer Health Advice Source Type: news
CDC Lifts HPV Vaccination Requirement For Young Female ImmigrantsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Starting Dec. 14, the U.S. will no longer require female immigrants seeking permanent resident status to be vaccinated against the human papillomavirus, the Centers for Disease Control and Prevention announced on Friday, the AP/San Francisco Chronicle reports. The new rule revises July 2008 guidelines that required female immigrants ages 11 through 26 seeking legal U.S. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This paper documents the progress of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National Institute for Health and Disability Insurance reimbursed the HPV vaccine for girls aged between 12-15 years. In December 2008, the age limit was extended to include girls up to the age of 18. In November 2008, the total number of HPV vaccines sold exceeded 530,000 doses. The number of vaccines reimbursed in Belgium, for the period November 2007-November 2008, corresponds to the amount required to f...
Source: Eurosurveillance latest news - November 19, 2009 Category: Infectious Diseases Source Type: journals
Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSIONS: This survey provides an update on sexual debut and behavior in young adults in some European countries. Estimated age at sexual debut ranged between 16 and 18 years and appeared to be later in girls than in boys. The proportion of girls sexually active before the age of 15 years was low (</=11.9%). Almost one-third of young women did not use a condom. This survey provides useful information to support current or planned HPV vaccination programs in Europe.
PMID: 19552945 [PubMed - in process] (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - November 18, 2009 Category: Cancer & Oncology Authors: Crochard A, Luyts D, di Nicola S, Gonçalves MA Tags: Gynecol Oncol Source Type: journals
Ethnic differences in human papillomavirus awareness and vaccine acceptabilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion:
These findings suggest some cultural barriers that could be addressed in tailored information aimed at ethnic minority groups. They also highlight the importance of recording ethnicity as part of HPV vaccine uptake data. (Source: Journal of Epidemiology and Community Health)
Source: Journal of Epidemiology and Community Health - November 18, 2009 Category: Epidemiology Authors: Marlow, L A V, Wardle, J, Forster, A S, Waller, J Tags: Epidemiologic studies, Cross-sectional studies, Ethnic studies Research reports Source Type: journals
Blogs Comment On Abortion Issues In Health Reform, HPV Vaccinations For ImmigrantsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The following summarizes selected women's health-related blog entries. ~ "DeGette: Stupak Agenda Is Much Wider Restrictions on Abortion," Brian Beutler, Talking Points Memo: Rep. Diana DeGette (D-Colo.) "takes issue" with Rep. Bart Stupak's (D-Mich.) "interpretation of the events leading up to the vote that completely changed the stakes of reform debate," Beutler writes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2009 Category: Consumer Health News Tags: Abortion Source Type: news
Soluble B and T Lymphocyte Attenuator Possesses Antitumor Effects and Facilitates Heat Shock Protein 70 Vaccine-Triggered Antitumor Immunity against a Murine TC-1 Cervical Cancer Model In Vivo.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
B and T lymphocyte attenuator (BTLA)-herpesvirus entry mediator (HVEM) signaling coinhibitory pathway is believed to impair antitumor immune competences. An intriguing unresolved question is whether blockade of BTLA-HVEM guides an effective therapeutic tool against established tumors. To address this issue, we constructed a eukaryotic expression plasmid (psBTLA) that expressed the extracellular domain of murine BTLA (soluble form of BTLA), which could bind HVEM, the ligand of BTLA, and block BTLA-HVEM interactions. The data in this study showed that treatment by injection of psBTLA resulted in down-regulation of IL-10 ...
Source: Journal of Immunology - November 18, 2009 Category: Allergy & Immunology Authors: Han L, Wang W, Fang Y, Feng Z, Liao S, Li W, Li Y, Li C, Maitituoheti M, Dong H, Lai Z, Gao Q, Xi L, Wu M, Wang D, Zhou J, Meng L, Wang S, Ma D Tags: J Immunol Source Type: journals
Less Than Half of College Women Vaccinated Against HPVEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new study shows that only 41% of young women in college are vaccinated against human papillomavi-rus; 30% of unvaccinated women believe the vaccine will "make them sick." Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2009 Category: Consumer Health News Tags: Public Health & Prevention Source Type: news
Green Card Seekers Won't Need HPV VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: WDSU.com - Health)
Source: WDSU.com - Health - November 17, 2009 Category: Consumer Health News Authors: WDSU.com Source Type: news
National Briefing | Immigration: Vaccine Requirement to Be EndedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: NYT)
Source: NYT - November 17, 2009 Category: American Health Authors: By THE ASSOCIATED PRESS Tags: vaccination and immunization human papilloma virus (HPV) Immigration and Emigration Centers for Disease Control and Prevention Women and Girls Source Type: news
Immigrant seekers won't have to get HPV vaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their permanent U.S. ... (Source: USATODAY.com Health)
Source: USATODAY.com Health - November 16, 2009 Category: Consumer Health News Source Type: news
Green Card Seekers Won't Have To Get HPV VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: WDSU.com - Health)
Source: WDSU.com - Health - November 16, 2009 Category: Consumer Health News Authors: WDSU.com Source Type: news
A 25-Year Analysis of Veterans Treated for Tonsillar Squamous Cell Carcinoma [Original Article]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion In veterans treated for tonsillar SCC, we advocate the consideration of a treatment plan that includes surgery for patients presenting with advanced-stage SCC of the tonsil, even in patients with notable comorbidities. (Source: Archives of Otolaryngology)
Source: Archives of Otolaryngology - November 16, 2009 Category: ENT & OMF Authors: jaber, J. J., Moreira, J., Canar, W. J., Bier-Laning, C. M. Tags: Oncology, Head & Neck cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Public Health, Tobacco, Radiation Therapy, Surgery, Surgical Interventions, Surgical Oncology, Prognosis/ Outcomes Original Article Source Type: journals
FDA approves cervical cancer vaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cervarix has won FDA approval for the prevention of cervical pre-cancers and cervical cancer associated with HPV-16 and HPV-18 for use in girls and young women (ages 10-25), according to GlaxoSmithKline. In clinical trials, the vaccine was shown to be 93% effective in the prevention of cervical pre-cancers associated with HPV -16 or 18, in women without evidence of current infection with, or prior exposure to, the same HPV type at the time of vaccination. (Source: Cancer Network)
Source: Cancer Network - November 16, 2009 Category: Cancer & Oncology Source Type: info
Centers For Medicare & Medicaid Services Approves FDG PET For Cervical Cancer StagingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SNM applauds the Centers for Medicare & Medicaid Services' (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions. "CMS' decision to expand coverage of FDG PET for the initial treatment strategy evaluation of cervical cancer is important for patient care," said Michael M. Graham, Ph.D., M.D., president of SNM. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Centers For Medicare & Medicaid Services Approves FDG PET For Cervical Cancer StagingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SNM applauds the Centers for Medicare & Medicaid Services' (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions. "CMS' decision to expand coverage of FDG PET for the initial treatment strategy evaluation of cervical cancer is important for patient care," said Michael M. Graham, Ph.D., M.D., president of SNM. (Source: MRI / PET / Ultrasound News From Medical News Today)
Source: MRI / PET / Ultrasound News From Medical News Today - November 14, 2009 Category: Radiology Tags: cervical cancer / HPV vaccine Source Type: news
Cervical cancer vaccine hope for African womenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DAR ES SALAAM (Reuters) - So crammed is Tanzania's only cancer treatment center that Rukia Kondogoza, wrapped in bright kanga cloth, has to share her bed with another patient. (Source: Reuters: Health)
Source: Reuters: Health - November 13, 2009 Category: Consumer Health News Tags: healthNews Source Type: news
HPV vaccine proposed for teen boysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Some doctors are concerned that the qualified recommendation from a CDC advisory panel could create insurance coverage problems. (Source: American Medical News - PROFESSION)
Source: American Medical News - PROFESSION - November 13, 2009 Category: American Health Source Type: news
Disease Progression And Survival Of Cervical Cancer Patients: Genetic Changes Are Important IndicatorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A study by Norwegian researchers published November 13 in the open-access journal PLoS Genetics reports that cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 13, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Disease Progression And Survival Of Cervical Cancer Patients: Genetic Changes Are Important IndicatorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A study by Norwegian researchers published November 13 in the open-access journal PLoS Genetics reports that cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes. Research suggests that specific genetic changes are critical steps in the progression of the disease towards an aggressive and treatment-resistant state. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 13, 2009 Category: Cancer & Oncology Tags: cervical cancer / HPV vaccine Source Type: news
[Case Report] Time to revisit mumps vaccination in Japan?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In June, 2008, a 30-year-old Japanese man presented to our emergency department with a sore throat and fever. The previous day he had been to a local clinic and prescribed antibiotics and non-steroidal anti-inflammatory drugs. However, treatment was ineffective and his fever increased (up to 38·1°C). On admission, he was transferred to our otolaryngology department with possible diagnosis of acute parotitis. He had a fever (38·0°C), was hoarse, and had difficulty speaking. His neck was very swollen with redness of the skin. There was no rash. We made a preliminary diagnosis of cervical abscess, rather than parotitis. L...
Source: LANCET - November 13, 2009 Category: Journals (General) Authors: Toru Sasaki, Koichi Tsunoda Tags: Case Report Source Type: journals
CERVARIX (Human Papillomavirus Bivalent (Types 16 And 18) Vaccine, Recombinant) Injection, Suspension [GlaxoSmithKline Biologicals SA]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Updated Date: Nov 12, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - November 12, 2009 Category: Drugs & Pharmacology Source Type: organizations
Poor value chlamydia screening programmeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
National Audit Office says £17m in savings could have been madeRelated items from OnMedicaCervical cancer vaccine choice criticisedMiddle-aged women may benefit from HPV vaccine Third of schools offer sex education clinicsGP incentives not always best for improving healthy lifestyleOver 45s take risks with their sexual health (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 12, 2009 Category: UK Health Source Type: news
An update on safety of Gardasil from DenmarkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - November 11, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals
Human papillomavirus vaccine recombinant quadrivalent: Various toxicities: 8 case reportsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - November 11, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals
Heat shock protein 110 improves the anti-tumor effects of the cytotoxic T lymphocyte epitope E7(49-57) in mice.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Several strategies have been used to enhance the vaccine-induced immunity of peptide vaccines and effective therapeutic benefits, including the utilization of heat shock proteins (HSP), especially the HSP70 family. HSP110 exhibits a higher binding affinity with protein and is capable of enhancing the immunogenicity of protein antigens; however, whether HSP110 can also increase the efficiency of peptide vaccine remains unclear. Here, we investigated mHSP110 as a chaperone immunoadjuvant to enhance the immune response to HPV16 oncoprotein E7-derived CTL epitope E7(49-57) in a mouse model. We developed the HSP110-E7(49-57...
Source: Cancer Biology and Therapy - November 11, 2009 Category: Cancer & Oncology Authors: Ren F, Xu Y, Mao L, Ou R, Ding Z, Zhang X, Tang J, Li B, Jia Z, Tian Z, Ni B, Wu Y Tags: cancer Biol Ther Source Type: journals
HPV Vaccine Clears Viral Infection And May Reduce Cancerous LesionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 11, 2009 Category: Cancer & Oncology Tags: cervical cancer / HPV vaccine Source Type: news
HPV Vaccine Clears Viral Infection And May Reduce Cancerous LesionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 11, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Early tests on cervical cancer drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
This small study has shown that the oestrogen receptor blockers fulvestrant and raloxifene can treat cervical cancers in genetically engineered mice with this disease. Although these results suggest that the drugs may be worth investigating further for potential use in human cervical cancer, they may not represent the effects that the drugs would have in humans. As the researchers note, “Although our transgenic mouse model for HPV-associated cervical cancer recapitulates most aspects of human cervical cancer, it is obvious that further study is needed to determine whether this proposed model is relevant to h...
Source: NHS News Feed - November 10, 2009 Category: Consumer Health News Tags: cancer Medical practice Source Type: news
Age-Specific Evaluation Of HPV DNA Testing Vs. Cytology ScreeningEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 10, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Age-Specific Evaluation Of HPV DNA Testing Vs. Cytology ScreeningEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. (Source: Genetics News From Medical News Today)
Source: Genetics News From Medical News Today - November 10, 2009 Category: Genetics & Stem Cells Tags: cervical cancer / HPV vaccine Source Type: news
FDA Approves Cervical Cancer VaccineEmail this article to a colleague.
Save this article to My Clippings.
1 CommentDiscuss or comment on this article.
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s human papillomavirus bivalent (types 16 and 18) vaccine, recombinant (Cervarix) for the prevention of cervical precancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10–25).
Women are at risk of HPV infecti (Source: Cancer Network)
Source: Cancer Network - November 10, 2009 Category: Cancer & Oncology Source Type: info
FDA-Approved Drugs Eliminate, Prevent Cervical Cancer In MiceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. Published in this week's (Nov. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 10, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Safety of Gardasil VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It's been about 18 months since the vaccine Gardasil has been on the market. The drug is designed to protect millions of girls and women against cervical cancer by preventing the human papilloma virus (HPV).
Today Barbara Lewis is joined by Dr. Marcia Shew, a specialist in adolescent medicine at Indiana University. She's been tracking the vaccine since its introduction. Shew discusses the usefu.... (Source: Sound Medicine)
Source: Sound Medicine - November 8, 2009 Category: Global & Universal Authors: Sound Medicine Source Type: info
Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease; Create High False Positive RatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 7, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease; Create High False Positive RatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 7, 2009 Category: Cancer & Oncology Tags: cervical cancer / HPV vaccine Source Type: news
HPV Vaccine Tailored to Prevent High-Grade VINEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A vaccine containing peptides targeting HPV-16 oncoproteins E6 and E7 was effective against high-grade, HPV-16-positive vulvar intraepithelial neoplasia, according to small phase II study results published... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - November 6, 2009 Category: Cancer & Oncology Source Type: news
Experimental Vaccine Shows Promise In Treating Precancerous Vulvar Growths, Study SaysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An experimental vaccine to treat precancerous vulvar growths eliminated the growths in nine of 20 women participating in a small trial, according to a study published in the New England Journal of Medicine, Reuters reports. The vaccine is intended to treat vulvar growths -- known as vulvar intraepithelial neoplasia -- that are caused by the human papillomavirus and can lead to vulvar cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 6, 2009 Category: Consumer Health News Tags: Women's Health / Gynecology Source Type: news
Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital WartsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 6, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital WartsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden. (Source: Pharma Industry News From Medical News Today)
Source: Pharma Industry News From Medical News Today - November 6, 2009 Category: Pharmaceuticals Tags: cervical cancer / HPV vaccine Source Type: news
HPV Vaccine May Prevent Breast CancersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
One of Australia's proudest scientific achievements of recent years, the vaccine against cervical cancer, may turn out to even more important than anyone Research published in the British Journal or" Cancer suggests that the vaccine may also prevent some breast cancers. (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 6, 2009 Category: Cancer & Oncology Source Type: news
Vaccine Effective for HPV-Related Vulvar Intraepithelial NeoplasiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An experimental vaccine induced a high rate of response in women with human papillomavirus (HPV)-16-positive, high-grade vulvar intraepithelial neoplasia. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 5, 2009 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Health Buzz: Bypass With Pump May Be Better for Patients and Other Health NewsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
4 ways to stop stressing out your kids; experimental new HPV vaccine may halt vulvar cancer. (Source: U.S. News - Health)
Source: U.S. News - Health - November 5, 2009 Category: Consumer Health News Source Type: consumer
Vaccine appears effective in HPV-16–positive, high-grade vulvular intraepithelial neoplasiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 5, 2009 Category: Cancer & Oncology Source Type: info
HPV Vaccine May Reverse Cancerous LesionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A small study found a new vaccine could treat the aftermath of HPV infection. (Source: ABC News: Health)
Source: ABC News: Health - November 5, 2009 Category: Consumer Health News Source Type: news
Many Physicians Do Not Follow Guidelines On Pap Testing, Study FindsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A survey of more than 1,200 primary care doctors in the U.S. found that less than 25% made Pap test recommendations that were fully in line with major guidelines, according to a study published Monday in the Annals of Internal Medicine, Reuters reports. The majority of doctors reported overusing the test, rather than failing to recommend it. The study, led by Robin Yabroff of the U.S. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 5, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Should Boys Be Vaccinated Against HPV?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new paper to be published in BJOG: An International Journal of Obstetrics and Gynaecology outlines a number of ongoing questions and challenges related to HPV vaccination. These include the decision to limit vaccination to adolescent girls, and the importance of continued screening. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 5, 2009 Category: Consumer Health News Tags: cervical cancer / HPV vaccine Source Type: news
Should Boys Be Vaccinated Against HPV?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new paper to be published in BJOG: An International Journal of Obstetrics and Gynaecology outlines a number of ongoing questions and challenges related to HPV vaccination. These include the decision to limit vaccination to adolescent girls, and the importance of continued screening. In 2008, the government launched a nationwide immunisation programme designed to protect British women against the devastating impact of cervical cancer. (Source: Men's health News From Medical News Today)
Source: Men's health News From Medical News Today - November 5, 2009 Category: Primary Care Tags: cervical cancer / HPV vaccine Source Type: news
New HPV Vaccine Might Stop Vulvar Cancer in its TracksEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Working differently than Gardasil, Cervarix, it targets inside of virus, study shows (Source: Forbes.com Health News)
Source: Forbes.com Health News - November 4, 2009 Category: Consumer Health News Source Type: news
New HPV Vaccine Might Stop Vulvar Cancer in Its TracksEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Working differently than Gardasil, Cervarix, it targets inside of virus, study shows Source: HealthDay
Related MedlinePlus Topics: HPV, Immunization, Vulvar Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 4, 2009 Category: Consumer Health News Source Type: consumer
